A new humanoid robot went from concept to live factory work in just seven months — and it’s now performing real industrial ...

PHAT remains a Hold as VOQUEZNA revenue ramps and opex improves, but leverage, dilution and valuation risk persist.

Centerspace (CSR) upgraded to Buy: strong NOI growth, high occupancy, 4.63% dividend, buybacks, and strategic review upside.

A quiet SGX holiday week saw a surprise REIT takeover bid, debt relief for Manulife US REIT, and NVIDIA’s largest-ever US$20 ...

On Friday, Alpha News released a video taken by the Immigration and Customs Enforcement Agent involved in the shooting of a ...

The latest research on DeFi Technologies centers on a sharp reset of the price target to US$2.50 from US$5.00, with analysts ...

The phrase '6-7' has captured the attention of both young audiences and cultural icons alike. Emerging from the catchy song 'Doot Doot (6 7)' by Skrilla, the term has gained traction on platforms like ...

In the worst-scenario, though, Emkay Global warns that Nifty may hit 25,000 in Q1-2026. Rupee weakness, and US tariff ...

In the rapidly evolving landscape of modern biotechnology, the precision of molecular tools determines the speed of medical breakthroughs. As a Global Leading Biotinylated Peptide Synthesis specialist ...

Results to be discussed in KOL event today at 10 a.m. ETBETHESDA, Md., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage ...

According to the report, HTX delivered robust growth last year across core metrics, such as user base, trading volume, and compliance. By year-end, the platform's global registered user base exceeded ...

Good morning and welcome to your Morning Briefing for Friday 9 January 2026. To get this in your inbox every morning click ...